Impressum / Imprint

2cureX GmbH
(Tochtergesellschaft der 2curex AS / subsidiary of 2curex AS https://www.2curex.com/contact/)

Spectrum Building at UKE
Martinistraße 64
20251 Hamburg
Germany

Tel.: +49 173 6000 704
E-Mail: info@2curex.com

Verantwortlich für den Inhalt nach § 55 II RStV / Responsible for the content according to § 55 II RStV
Dr. Jürgen Kupper, Geschäftsführer

Vertreten durch / Represented by
Dr. Jürgen Kupper, Geschäftsführer

Gesellschafter / Shareholder
2cureX AS Vertreten durch / Represented by Prof. Ole Thastrup, Chief Executive Officer

Handelsregistereintrag / Commercial Register
HRB 137736, Amtsgericht Hamburg

Umsatzsteuer-ID-Nr. / VAT ID
DE303308758

Ausstellende Behörde / Issuing Authority
Hansestadt Hamburg

Upcoming events

October 13, 2022

2cureX presents at Redeye Investor AW in Malmø, Sweden

Redeye events list

October 26, 2022

2cureX presents at Redeye Medtech event in Stockholm, Sweden

Redeye events list

November 24, 2022

Interim Report Q3 2022 released

View previous reports

November 24, 2022

Q3 Report webcast and Q&A session

IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.